Cargando…

Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study

BACKGROUND AND OBJECTIVES: Previous studies have highlighted antidiabetic drugs as repurposing candidates for Alzheimer disease (AD), but the disease-modifying effects are still unclear. METHODS: A 2-sample mendelian randomization study design was applied to examine the association between genetic v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Bowen, Wang, Yunzhang, Jiang, Xia, Thambisetty, Madhav, Ferrucci, Luigi, Johnell, Kristina, Hägg, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484609/ https://www.ncbi.nlm.nih.gov/pubmed/35654594 http://dx.doi.org/10.1212/WNL.0000000000200771

Ejemplares similares

Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
por: Tang, Bowen, et al.
Publicado: (2023)

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
por: Qin, Chenxi, et al.
Publicado: (2023)

Fatty Acids and Frailty: A Mendelian Randomization Study
por: Tomata, Yasutake, et al.
Publicado: (2021)

Protein Nutritional Status and Frailty: A Mendelian Randomization Study
por: Tomata, Yasutake, et al.
Publicado: (2021)

Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank
por: Wang, Qi, et al.
Publicado: (2019)

Circulating antioxidants and Alzheimer disease prevention: a Mendelian randomization study
por: Williams, Dylan M, et al.
Publicado: (2019)

Polyunsaturated fatty acids and risk of Alzheimer’s disease: a Mendelian randomization study
por: Tomata, Yasutake, et al.
Publicado: (2019)

Unraveling the metabolic underpinnings of frailty using multicohort observational and Mendelian randomization analyses
por: Mak, Jonathan K. L., et al.
Publicado: (2023)

Reciprocal interaction between depression and pain: results from a comprehensive bidirectional Mendelian randomization study and functional annotation analysis
por: Tang, Bowen, et al.
Publicado: (2022)

Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
por: Roberts, Jackson A., et al.
Publicado: (2023)

Circulating insulin-like growth factors and Alzheimer disease: A mendelian randomization study
por: Williams, Dylan M., et al.
Publicado: (2018)

Obesity and Longer Term Risks of Dementia in 65–74 Year Olds
por: Bowman, Kirsty, et al.
Publicado: (2019)

Unraveling the genetic complexity of Alzheimer disease with Mendelian Randomization
por: Bandres-Ciga, Sara, et al.
Publicado: (2019)

Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults
por: Chuang, Yi-Fang, et al.
Publicado: (2017)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Association between genetically predicted telomere length and facial skin aging in the UK Biobank: a Mendelian randomization study
por: Zhan, Yiqiang, et al.
Publicado: (2020)

Dynamic patterns of blood lipids and DNA methylation in response to statin therapy
por: Qin, Xueying, et al.
Publicado: (2022)

Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
por: Hägg, Sara, et al.
Publicado: (2020)

Correction to: Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
por: Hägg, Sara, et al.
Publicado: (2021)

Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease
por: Meng, Lei, et al.
Publicado: (2022)

Leukocyte DNA methylation in Alzheimer´s disease associated genes: replication of findings from neuronal cells
por: Karlsson, Ida K, et al.
Publicado: (2022)

Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017)

Implementing a method for studying longitudinal DNA methylation variability in association with age
por: Wang, Yunzhang, et al.
Publicado: (2018)

Antidiabetic therapies and Alzheimer disease
por: Bendlin, Barbara B
Publicado: (2019)

Clinical biomarkers and associations with healthspan and lifespan: Evidence from observational and genetic data
por: Li, Xia, et al.
Publicado: (2021)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review
por: Johnell, Kristina
Publicado: (2015)

Genetically proxied antidiabetic drugs targets and stroke risk
por: Zhu, Yahui, et al.
Publicado: (2023)

Systematic Identification of circRNAs in Alzheimer’s Disease
por: Cochran, Kyle R., et al.
Publicado: (2021)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Frailty and the risk of dementia: is the association explained by shared environmental and genetic factors?
por: Bai, Ge, et al.
Publicado: (2021)

A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
por: Shi, Liu, et al.
Publicado: (2018)

Regional variations in excessive polypharmacy and potentially inappropriate drug use among older adults in Sweden: Trends from 2006 to 2020
por: Wastesson, Jonas W., et al.
Publicado: (2023)

Genetically predicted telomere length and Alzheimer’s disease endophenotypes: a Mendelian randomization study
por: Rodríguez-Fernández, Blanca, et al.
Publicado: (2022)

Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project
por: Secnik, Juraj, et al.
Publicado: (2023)

Extra cup of tea intake associated with increased risk of Alzheimer’s disease: Genetic insights from Mendelian randomization
por: Sun, Yuxuan, et al.
Publicado: (2023)

Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
por: Park, Sehoon, et al.
Publicado: (2023)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
por: Benn, Marianne, et al.
Publicado: (2017)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
Publicado: (2017)

National Indicators for Quality of Drug Therapy in Older Persons: the Swedish Experience from the First 10 Years
por: Fastbom, Johan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ni77bhfqphgkoa0tchra7tljlv